Gelatin Market

The market for Gelatin was estimated at $4.4 billion in 2025; it is anticipated to increase to $6.2 billion by 2030, with projections indicating growth to around $8.8 billion by 2035.

Report ID:DS1901203

Author:Debadatta Patel - Senior Consultant

Published Date:June 2025

Datatree

Food & Beverage

Packaged & Processed F&B

Gelatin

Customization Available

Gelatin - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Gelatin Market Outlook

Revenue, 2025

$4.4B

Forecast, 2035

$8.8B

CAGR, 2026 - 2035

7.1%

The Gelatin industry revenue is expected to be around $4.4 billion in 2026 and expected to showcase growth with 7.1% CAGR between 2026 and 2035. The Gelatin market now plays a key part as a key protein source in foods, medicines, and hygiene products driven by more people wanting clean labels made from natural ingredients. Because it helps control consistency and binding, nearly two thirds of usage goes to stabilizing and thickening tasks, showing how vital Gelatin is for shaping taste, structure, and initial sensation in premium edible items and dietary supplements. Looking at where Gelatin is used most, B leads earnings, bringing in roughly $2.49 billion in 2025, helped by its ability to work well with cattle and pig derived materials, while also being cheaper and widely used in medicine making and pill coatings. Fresh investment flows into high end gelatin variants, boosting flower intensity while improving dissolving traits alongside broader market entry by dominant players, making the sector harder to shake despite shifts in the market landscape

When heated, gelatin loses its gel state, yet returns when cooled a trait rooted in collagen origins. Its ability to create transparent films stands alongside robust moisture retention and thermal sensitivity. Across food platforms, from candies to yogurts and processed meats, it plays key roles due to stability and texture modulation. Beyond kitchens, pharmaceutical settings rely on it for capsule contents, coating layers, and loose gel formulations. Supplements also use it extensively as a base or delivery agent. Beyond standard uses, beauty companies now embed Gelatin or collagen into creams, shampoos, and salves targeting skin, locks, or cuticles. Because the body tolerates it well, researchers are pushing Gelatin into newer medical roles like healing wounds, building tissues, or slowly releasing drugs where needed. Lately, people have turned more toward real food pieces instead of artificial stuff. This move plus rising demand in supplements and health drinks fuels activity now. New ways to package nutrients through improved forms keep appearing too. Custom mixes tailored to specific needs show up more frequently than before. Another shift buyers want assurance about where the gelatin comes from, how its treated, and whether it holds proper approvals. That angle pushes things forward quietly behind the scenes.

Gelatin market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Gelatin Market Outlook

Market Key Insights

The Gelatin market is projected to grow from $4.4 billion in 2025 to $8.8 billion in 2035. This represents a CAGR of 7.1%, reflecting rising demand across Food Industry, Pharmaceutical Industry, and Cosmetics & Personal Care.
Companies like Gelita AG, Rousselot, and PB Leiner hold strong positions within this space.
The United States and China lead in the gelatin market right now. Growth here isn’t slowing down numbers show rates between 4.6% and 6.8% annually from 2025 to 2030.
Out in places like Vietnam, Mexico, and Turkey, things are looking up growth numbers hit between 8.2% and 9.8%, marking a clear climb ahead.
As awareness grows, patterns shift especially in the U.S. and China where health concerns reshape how value flows through the gelatin sector. By 2030, that shift may unlock another $157 million in revenue.
A jump in demand could push the Gelatin market forward by $4.4 billion within 7 years starting 2025. Manufacturers eyeing growth see potential swelling especially in drugs and personal care products those region's may claim even bigger slices of the pie.
With
food and beverage industry growth, and
Advancements in Pharmaceutical Applications, Gelatin market to expand 99% between 2025 and 2035.

Gelatin - Country Share Analysis

Opportunities in the Gelatin

Pharmaceutical makers in India now demand better quality gelatin with stricter controls on flow, purity, and tracking for making both rigid and flexible capsules. Custom made B gelatin that suits fast production of generic medicines could also unlock new value. This kind of gelatin sees global growth, rising from $2.49 billion in 2025 to 3.48 billion by 2030 at 6.86% yearly pace. India drives more volume than its share of the trend, shaping outcomes in ways not only seen before.

Growth Opportunities in North America and Asia-Pacific

A rise in using gelatin to stabilize and thicken foods like enriched milk drinks, low sugar sweets, and pill forms marks growing trends across North America. Clean labels without common allergens now rank high among preferred formulations. Custom gelatin mixes tailored for making soft or rigid capsules stand out in industry use. Premium lines featuring collagen loaded with benefits appeal to buyers focused on performance and age related well being. Pricing here tends to hold steady despite broader market shifts. A few dominant players dominate the scene, including firms that handle both raw materials and processing. Yet openings still exist especially for those providing animal source gelatin with clear origin tracking. Certifications aligned with religious dietary rules also gain attention. Additionally, working closely with clients to adapt technology helps shape unique ingredient needs for functional foods. Driven by tough safety rules, people are paying more attention to protein and collagen bits. At the same time, packaged snacks are shifting getting smoother, lasting longer, while ditching artificial ingredients.

A surge in Asia Pacific’s Gelatin market comes from its role as a thickener and gelling agent across sweets, desserts, drinks, and emerging health foods. This region draws strong interest due to its ability to scale up affordable collagen and food gelatin. Localized manufacturing lines up with key animal sourcing centers, supporting efficient supply chains. Halal certified gelatin gains traction as markets like Singapore and Malaysia demand compliant products. Texture demands vary widely from familiar Asian desserts to Western snack formats offering many functional angles for gelatin use. Notable players still operate in scattered units, each vying mainly on low costs. Meanwhile, global firms aim sharper at purity levels, delivering medical quality or performance focused forms mainly used in pills, chewable items, and internal wellness treatments. Increasing household income plays a role. City life brings changes people want easier to consume packaged meals. More consumers now understand how collagen health items can help them feel better. Rules are getting sharper too, focusing on safety, where animal sources like cows and pigs come from, and whether they meet religious standards all shaping how gelatin is handled here.

Market Dynamics and Supply Chain

Driver: Growing Consumer Demand for Natural, Functional Ingredients and Rising Pharmaceutical Applications

The gelatin market is also being driven by two interconnected growth factors-increasing consumer preference for natural, clean-label ingredients and expanding applications in pharmaceuticals. First, consumers worldwide are also seeking products made from natural and functional ingredients, particularly in food, nutraceuticals, and personal care. Gelatin, sourced from collagen and used as a gelling and stabilizing agent, aligns with the clean-label trend, encouraging manufacturers to use it in gummies, dairy products, and protein-enriched foods that resonate with health-oriented buyers. This trend is also boosted by growing awareness of health benefits such as joint and skin support, which makes gelatin desirable in functional foods and supplements. Second, the pharmaceutical industry’s expansion is also heightening demand for gelatin in soft and hard capsules, tablet coatings, and advanced drug delivery systems because of its biocompatibility and digestibility. The increase in pharmaceutical output, including nutraceuticals, has also significantly contributed to overall gelatin consumption, supporting stable market growth across sectors.

A key driver of the gelatin market is also the growing emphasis on Halal, Kosher certifications and ethical sourcing, which expands the product’s appeal across diverse demographic and geographic segments. Manufacturers are also increasingly offering certified gelatin from various raw materials such as bovine, porcine, and marine sources to meet dietary and cultural requirements in markets with stringent halal or kosher standards. This trend not only broadens the consumer base but also enhances market penetration in growth regions where religious compliance is also crucial, supporting product adoption in food, pharmaceutical, and personal care applications.

Restraint: Cultural, Religious, and Dietary Restrictions Limit Gelatin Adoption and Market Reach

The animal-derived nature of traditional gelatin significantly constrains market expansion, as many consumers avoid porcine or bovine collagen for cultural, religious, or personal dietary reasons. Gelatin is unsuitable for large segments of Muslim and Jewish populations without Halal or Kosher certification, and vegetarians or vegans reject animal-sourced ingredients altogether, shrinking potential demand in key regions like the Middle East, South Asia, and Western urban markets. This dynamic forces food, pharmaceutical, and cosmetic producers to reformulate products with alternative gelling agents, eroding gelatin’s revenue base and slowing growth in segments where plant-based substitutes gain preference.

Opportunity: Rapidly expanding nutraceutical gummy supplements market among aging populations in North America and Western Europe and Medical-grade gelatin biomaterials for regenerative wound care and tissue engineering applications across East Asian hospitals

Even as aging populations increasingly seek support for joint, bone, and skin health, many consumers have not yet fully adopted gelatin-based gummy supplements. The use of Type A gelatin, commonly employed in soft gummies and chewables, offers clear advantages over plant-based alternatives, including superior texture, visual clarity, and higher protein content. Gelatin-based gummies also provide a smoother mouthfeel and improved bioavailability, making them particularly suitable for senior nutrition and wellness applications. Market data indicates that global spending on Type A gelatin is projected to increase from USD 1.94 billion in 2025 to USD 2.77 billion by 2030, representing a robust 7.4% compound annual growth rate. This trend is creating strong opportunities for premium, clean-label gummy supplements tailored to personalized nutrition, as older consumers increasingly prioritize convenient, effective, and high-quality wellness solutions.

With more money going into hospital focused regenerative care, scientists need special gels made from gelatin like mesh forms, absorbent pads, or driable gels to help wounds heal and grow new tissue. Even now, Eastern Asian medical networks depend mostly on foreign made biological supplies. That habit opens doors for local firms making pure A gelatin that swells well yet carries low bacterial contamination. By teaming up smartly between gelatin makers, innovation labs in medicine, and research clinics attached to hospitals, these players gain faster access to approval marks and proof of safety in human trials. Over time, such efforts turn parts of the region into key zones for advanced temporary tissue tools designed to vanish over time.

Challenge: Raw Material Supply Volatility and Production Cost Pressures Constrain Market Stability

Gelatin production depends heavily on animal by-products from meat and leather industries, making it vulnerable to supply fluctuations, quality variability, and regulatory constraints on livestock processing. Disruptions such as disease outbreaks, seasonal variations, or shifts in meat consumption can reduce availability of hides, bones, and skins, driving price volatility and increasing operational costs for manufacturers. These supply chain vulnerabilities limit consistent production, elevate prices, and reduce profit margins, particularly affecting smaller producers and dampening overall market momentum in food, pharmaceutical, and personal care applications.

Supply Chain Landscape

Collagen Sourcing

JBSTyson FoodsCargill

Gelatin Processing

Gelita AGRousselotPB Leiner

Gelatin Ingredients

Nitta Gelatin NA Inc.SAS Gelatines WeishardtGelita AG

Gelatin End-use

Food & BeveragesPharmaceuticals

Collagen Sourcing

JBSTyson FoodsCargill

Gelatin Processing

Gelita AGRousselotPB Leiner

Gelatin Ingredients

Nitta Gelatin NA Inc.SAS Gelatines WeishardtGelita AG

Gelatin End-use

Food & BeveragesPharmaceuticals

Gelatin - Supply Chain

Use Cases of Gelatin in Food & Pharmaceutical

Food Industry : In the food industry, gelatin is predominantly used as an edible gelling and stabilizing agent in confectionery, desserts, dairy products, and processed foods, providing elasticity, texture, and mouthfeel that are difficult to achieve with alternatives. It helps form the characteristic chewiness in gummies and marshmallows and improves moisture retention in yogurts and creams, appealing to consumer preferences for indulgent and clean-label products. Major suppliers such as Gelita AG, Rousselot, and PB Leiner dominate this space by offering high-quality edible gelatin tailored to bakery, confectionery, and dairy applications, supporting food manufacturers with consistent supply and technical support while maintaining strong global distribution networks.

Pharmaceutical Industry : In the pharmaceutical industry, pharmaceutical-grade gelatin is essential for making hard and soft capsules, tablet coatings, and certain controlled-release formulations, owing to its biocompatibility, digestibility, and strong film-forming properties. Gelatin enhances drug stability and bioavailability, making it indispensable in drug delivery systems and nutraceuticals. Key players such as ACG, Rousselot, and Nitta Gelatin provide specialized gelatin grades that meet stringent regulatory and quality standards, reinforcing their market positions by focusing on innovation, safety, and global compliance for pharmaceutical manufacturers.

Cosmetics & Personal Care : In cosmetics and personal care, gelatin and its collagen derivatives are valued for moisture retention, elasticity improvement, and film-forming properties in skincare creams, face masks, and hair care formulations. These functional benefits support anti-aging, hydration, and texture enhancement, aligning with growing consumer demand for natural and performance-oriented beauty products. Players like Gelita AG and Weishardt Group supply cosmetic-grade gelatin that integrates seamlessly into formulations, strengthening their presence in the personal care segment through product quality, formulation expertise, and responsiveness to emerging beauty trends.

Recent Developments

The gelatin market is evolving as demand rises across nutraceuticals, pharmaceuticals, and functional food applications, driven by aging populations and clean-label preferences. Recent developments highlight growth in Type A and Type B gelatin for advanced drug delivery systems, soft and hard capsules, and high-protein gummy supplements. A key trend is the expansion of certified halal and kosher gelatin to broaden geographic penetration and meet diverse dietary requirements. Producers are also investing in sustainable sourcing and traceability, reinforcing quality assurance and supply chain resilience.

May 2025 : In May 2025, Darling Ingredients’ Rousselot and PB Leiner agreed to combine their collagen and gelatin businesses into a new global joint venture called Nextida, aiming to leverage combined R&D, production, and commercial scale with projected annual revenue of about USD 1.5 billion and operations across four continents.

June 2025 : Gelita AG introduced RAPISOL, an innovative gelatin designed for softgel capsules that enables up to three times faster release compared with standard gelatin capsules, enhancing performance for pharmaceutical applications.

Impact of Industry Transitions on the Gelatin Market

As a core segment of the Packaged & Processed F&B industry, the Gelatin market develops in line with broader industry shifts. Over recent years, transitions such as Rise in Health Consciousness and Evolution of Pharmaceutical Applications have redefined priorities across the Packaged & Processed F&B sector, influencing how the Gelatin market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Rise in Health Consciousness

The gelatin market is undergoing a significant transformation driven by increasing health awareness, particularly in the U.S. and China, where consumers are redefining value perceptions. Gelatin, once merely a food additive, is now recognized for its potential benefits in joint, skin, and digestive health, leading to a surge in demand for supplements and enriched products. This shift is projected to unlock an additional $157 million in revenue by 2030, as companies that enhance the quality and safety of their gelatin offerings position themselves to capture the growing market of health-conscious consumers. Firms that adapt swiftly to these evolving consumer preferences and emphasize the nutritional benefits of gelatin-rich products will not only enhance their profitability but also strengthen their market presence in a competitive landscape.

Evolution of Pharmaceutical Applications

It reflects a significant transition in how the pharmaceutical industry utilizes gelatin. Traditionally valued mainly as a thickening or binding agent in tablets, gelatin now plays a much broader role due to its biocompatibility, biodegradability, and film-forming properties. It is widely used in hard and soft capsules, advanced drug delivery systems, wound dressings, and tissue regeneration applications. Scientific progress in controlled-release formulations and biomedical engineering has expanded gelatin’s functionality beyond conventional dosage forms. This transition has also influenced related industries such as nutraceuticals, medical devices, and regenerative medicine, driving demand for pharmaceutical-grade and specialty gelatin. As innovation continues, gelatin’s role in enhancing drug stability, patient compliance, and therapeutic effectiveness is becoming increasingly central to modern pharmaceutical development.